On air · 2 of 3 networks
Gericke Group
- gerickegroup.com
- Industry & Manufacturing
- CH
- 303 employees
Gericke Group’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 39. Watch Gericke Group with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 14 | Checked 28 Oct 2026 | See all 39 ads → | ||
| Meta | Not checked | — | |||
| Running | 100+ | Ads on the Google Ads Transparency Center | Checked 30 Oct 2026 | Collect them with the API → |
Gericke Group has 14 live LinkedIn ads. We recorded 100+ Google ads on 30 Oct 2026.
Latest ads
- LINKEDIN · VIDEOSince 2 Sept 2026
Gericke – sprawdzony partner w zakresie rozwiązań do transportu materiałów sypkich i przetwarzania proszków. Nasz wielojęzyczny zespół chętnie pomoże w analizie i optymalizacji konkretnych potrzeb, oferując rozwiązania dostosowane do indywidualnych wymagań w następujących obszarach: - Precyzyjne dozowanie i podawanie - Energooszczędny transport materiałów - Szybkie, równomierne i delikatne mieszanie oraz homogenizacja - Kompletne systemy „pod klucz” i zaawansowana automatyzacja - oraz wiele więcej! W firmie Gericke łączymy ponad 132 lata doświadczenia w zakresie innowacji i rozwoju technologicznego, aby zwiększyć wydajność Twoich procesów. Skontaktuj się z nami i dowiedz się, jak możemy wesprzeć Twoją działalność! [email protected]
- LINKEDIN · VIDEOSince 29 Aug 2026
In pharmaceutical scale-up, each process transfer introduces variability, additional validation effort, and regulatory risk. All of this leads to a delayed market-entry. GFS Gen3 removes that: • one continuous process across all phases → faster time to patient • reduced validation and transfer effort → lower regulatory risk • flexible containment solutions → safe handling of potent APIs
- LINKEDIN · IMAGESince 17 Aug 2026
Variability in powder flow, feeding, or blending leads to repeated trials, inconsistent data, and delayed process decisions. GFS Gen3 ensures stability in continuous manufacturing from the start: ✅ continuous powder flow ✅ precise dosing ✅ controlled blending conditions This results in reliable data, fewer iterations, and more efficient API usage — helping you move faster with confidence.
- LINKEDIN · IMAGESince 10 Aug 2026
In pharmaceutical development, containment must remain consistent across all phases to avoid redesign and regulatory delays. #Gericke's GFS Gen3 provides: ✅ flexible containment for ingredients classified from OEB 3 to OEB 5 ✅ consistent safety concept across all stages ✅ compliant handling from development to production This enables safe handling of even highly potent APIs — without disrupting your process.
- LINKEDIN · VIDEOSince 3 Aug 2026
Complex equipment and setup procedures slow down formulation development and make process optimization more difficult. GFS Gen3 is designed for simple, repeatable operation in continuous manufacturing: • poka-yoke setup • fixed, repeatable positions • reduced system complexity This allows faster setup, easier experimentation, and reproducible results — from development to production.
- LINKEDIN · IMAGESince 28 Jul 2026
GFS Gen3 keeps it simple: ✅ one system from early trials to production without scale-up ✅ full modularity for optimized process conditions ✅ highest product quality across all phases ✅ adaptable containment solutions for your needs This enables faster development, efficient API use, and a smoother path to patient. Your highest demands made possible through #Gericke’s simple solutions – we got you covered.
6 of 39 adsSign up to see every Gericke Group ad, filter by format and date, and get alerts on new ones.
See all 39 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.